986 related articles for article (PubMed ID: 27871809)
1. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
[TBL] [Abstract][Full Text] [Related]
2. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.
Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S
Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777
[TBL] [Abstract][Full Text] [Related]
3. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
[TBL] [Abstract][Full Text] [Related]
5. Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.
La Manna MP; Orlando V; Li Donni P; Sireci G; Di Carlo P; Cascio A; Dieli F; Caccamo N
PLoS One; 2018; 13(3):e0192664. PubMed ID: 29543810
[TBL] [Abstract][Full Text] [Related]
6. Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker.
Borgström E; Andersen P; Atterfelt F; Julander I; Källenius G; Maeurer M; Rosenkrands I; Widfeldt M; Bruchfeld J; Gaines H
PLoS One; 2012; 7(11):e43438. PubMed ID: 23144772
[TBL] [Abstract][Full Text] [Related]
7. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
[TBL] [Abstract][Full Text] [Related]
8. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection.
Wu J; Wang S; Lu C; Shao L; Gao Y; Zhou Z; Huang H; Zhang Y; Zhang W
Tuberculosis (Edinb); 2017 Jan; 102():68-75. PubMed ID: 28061954
[TBL] [Abstract][Full Text] [Related]
9. Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting.
Clifford V; Tebruegge M; Zufferey C; Germano S; Forbes B; Cosentino L; Matchett E; McBryde E; Eisen D; Robins-Browne R; Street A; Denholm J; Curtis N
Tuberculosis (Edinb); 2019 Jan; 114():91-102. PubMed ID: 30711163
[TBL] [Abstract][Full Text] [Related]
10. The impact of anti-tuberculous antibiotics and corticosteroids on cytokine production in QuantiFERON-TB Gold In Tube assays.
Clifford V; Zufferey C; Germano S; Ryan N; Leslie D; Street A; Denholm J; Tebruegge M; Curtis N
Tuberculosis (Edinb); 2015 May; 95(3):343-9. PubMed ID: 25837441
[TBL] [Abstract][Full Text] [Related]
11. Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosis.
Clifford V; Tebruegge M; Zufferey C; Germano S; Forbes B; Cosentino L; McBryde E; Eisen D; Robins-Browne R; Street A; Denholm J; Curtis N
J Infect; 2017 Aug; 75(2):132-145. PubMed ID: 28483404
[TBL] [Abstract][Full Text] [Related]
12. Levels of vitamin D-associated cytokines distinguish between active and latent tuberculosis following a tuberculosis outbreak.
Hong Y; Kim Y; Lee JJ; Lee MG; Lee CY; Kim Y; Heo J; Han SS; Lee SJ; Kim WJ; Hong JY
BMC Infect Dis; 2019 Feb; 19(1):151. PubMed ID: 30760247
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population.
Wang S; Diao N; Lu C; Wu J; Gao Y; Chen J; Zhou Z; Huang H; Shao L; Jin J; Weng X; Zhang Y; Zhang W
PLoS One; 2012; 7(12):e51338. PubMed ID: 23272100
[TBL] [Abstract][Full Text] [Related]
15. Combined Analysis of IFN-γ, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection.
Suzukawa M; Akashi S; Nagai H; Nagase H; Nakamura H; Matsui H; Hebisawa A; Ohta K
PLoS One; 2016; 11(4):e0152483. PubMed ID: 27035669
[TBL] [Abstract][Full Text] [Related]
16. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
17. Potential biomarkers associated with discrimination between latent and active pulmonary tuberculosis.
Kamakia R; Kiazyk S; Waruk J; Meyers A; Ochanda J; Ball TB; Oyugi J
Int J Tuberc Lung Dis; 2017 Mar; 21(3):278-285. PubMed ID: 28225338
[TBL] [Abstract][Full Text] [Related]
18. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects.
You E; Kim MH; Lee WI; Kang SY
Tuberculosis (Edinb); 2016 Jul; 99():100-108. PubMed ID: 27450011
[TBL] [Abstract][Full Text] [Related]
20. Alternative biomarkers for classification of latent tuberculosis infection status in pregnant women with borderline Quantiferon plus results.
Tesfaye F; Sturegård E; Walles J; Winqvist N; Balcha TT; Karlson S; Mulleta D; Isberg PE; Jansson M; Björkman P
Tuberculosis (Edinb); 2020 Sep; 124():101984. PubMed ID: 32829076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
